Lamivudine Reverses Severe Acute Hepatitis B and Pancytopenia After Renal Transplantation: A Case Report

Treatment of Acute Hepatitis B with Nucleoside and/or Nucleotide Analogues

“…Nevertheless, lamivudine has the most available data evaluating its use in acute hepatitis B among the oral antiviral agents. Although much of the data are limited to case reports [12,13] and case series [14,15], mostly involving immunocompromised patients with hematologic malignancies [16], transplant recipients [17][18][19][20][21][22], or patients with extrahepatic manifestations of the disease [23,24], a few small studies have been published with reports of good outcomes in immunocompetent individuals.…”